PDCD1 and neoplasm: To this end, we used a murine patient-derived xenograft (PDX) model of squamous NSCLC devoid of host lymphoid cells, and compared the tumor and immune non-lymphoid responses to immunotherapy with anti-PD-1 alone or in combination with standard chemotherapy.